Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cprx · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$32.00
Consensus
$31.75
+1.5% upside
Low
$31.50
Median: $31.75 · Last Close: $31.27
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$31.75
1.5% upside
High Target
$32
2.3%
Low Target
$31.5
0.7%
Current Price
$31.27
as of today
Based on analyst price targets, the CPRX stock price prediction for the next 12 months ranges from $31.5 to $32. The consensus CPRX price forecast of $31.75 implies 1.5% upside from the current price of $31.27.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $31.27 | ↑ 0.01% |
1-day model range: $31.16–$31.39. Peak: $31.39 (+0.01%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $46 | +48.4% |
| 2028 | $60 | +91.6% |
| 2029 | $70 | +125.0% |
| 2030 | $78 | +148.6% |
| 2031 | — | +164.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CPRX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2026-05-08 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2026-05-07 | Stephens & Co. | Downgrade ↓ | Overweight→Equal Weight |
| 2026-03-03 | Citigroup | Maintains | Buy→Buy |
| 2025-11-07 | Citigroup | Maintains | Buy→Buy |
| 2025-03-03 | Baird | Maintains | Outperform→Outperform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-27 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2025-01-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-09 | B of A Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Catalyst Pharmaceuticals, Inc. (CPRX) stock. Of the recent 61 rating actions, 3 were upgrades and 6 were downgrades. 16 analysts currently cover CPRX.
Analyst Recommendation Trends
CPRX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$633M
↓ 17.4% YoY
Revenue Next Year
$703M
↑ 11.1% YoY
EPS This Year
$1.92
EPS Next Year
$2.24
↑ 16.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CPRX EPS of $1.92 for the current fiscal year, based on estimates from 3 analysts. The CPRX revenue forecast is $633M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CPRX stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CPRX price target is $31.75 (+1.5% upside), with an analyst consensus of Buy.
The CPRX short-term stock prediction for tomorrow is $31.27 (+0.01%). The CPRX stock price prediction for 2027 estimates an average of $46. The CPRX stock prediction for 2030 projects a range of $75–$81.
Catalyst Pharmaceuticals, Inc. trades on NASDAQ under the ticker CPRX. The CPRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
CPRX forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month CPRX price target is $31.75, with a high forecast of $32.00 and a low of $31.50. The median price target is shown in the chart above when available. This implies +1.5% potential upside from the current price of $31.27.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.